More articles from Slide Presentation

You have access
Current European Regulations for Control of Adventitious Virus Safety
Johannes Blümel

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 568-579; DOI: https://doi.org/10.5731/pdajpst.2011.00821
You have access
Viral Safety of Plasma-derived Products
Mahmood Farshid

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 737-753; DOI: https://doi.org/10.5731/pdajpst.2011.00848
You have access
FDA Post-Approval Expectations for Adventitious Virus Contamination Prevention
Richard L. Friedman

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 698-712; DOI: https://doi.org/10.5731/pdajpst.2011.00846
You have access
Application of Quality by Design in the Control of Adventitious Viruses: Gaps in Current Processes in the Prevention of Virus Contaminants
Barry Cherney

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 754-766; DOI: https://doi.org/10.5731/pdajpst.2011.00849
You have access
A Biotech Production Facility Contamination Case Study—Minute Mouse Virus
Jim Skrine

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 599-611; DOI: https://doi.org/10.5731/pdajpst.2011.00823

Main menu